GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GHRS is expected to report earnings to rise 60.00% to -23 cents per share on November 06
Q3'25
Est.
$-0.24
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.01
The last earnings report on August 07 showed earnings per share of -15 cents, beating the estimate of -20 cents. With 84.43K shares outstanding, the current market capitalization sits at 725.12M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GHRS showed earnings on August 07, 2025. You can read more about the earnings report here.